2020 Revenues ($USD) : $4,303,000,000 2020 R&D spend : not available 2020 Number of Employees : not available Fiscal Year End : 12/31/2020 Key People : Robert Ford, CEO
Even after it spun off AbbVie at the start of 2013, Abbott kept an established pharmaceuticals business. Products in the business provide treatments in spaces including gastroenterology, women's health, cardiovascular, pain and central nervous system, and respiratory. Established pharmaceuticals make up more than 12% of Abbott's revenue. –CN
Abbott facility in China. Image courtesy of Abbott Laboratories.